Search research articles
Contact Us
Filters
Showing results (341-350 of 362) with videos related to
Page
of 37
Sort By:
European Journal of Heart Failure
|
August 15, 2019
Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry
Maja Cikes, Nina Jakus, Brian Claggett, et al.
Circulation. Genomic and Precision Medicine
|
January 24, 2025
Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy
Alexandra Butters, Clare Arnott, Joanna Sweeting, et al.
JAMA
|
December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial
Orly Vardeny, KyungMann Kim, Jacob A Udell, et al.
Circulation
|
November 19, 2021
Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial
Marc A Pfeffer, Brian Claggett, Eldrin F Lewis, et al.
BMJ Open
|
May 25, 2022
Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis
Joseph E Ebinger, Sandy Joung, Yunxian Liu, et al.
The New England Journal of Medicine
|
November 10, 2021
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction
Marc A Pfeffer, Brian Claggett, Eldrin F Lewis, et al.
Circulation
|
November 19, 2019
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF
John J V McMurray, Alice M Jackson, Carolyn S P Lam, et al.
Journal of the American College of Cardiology
|
September 11, 2025
Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM
Sheila M Hegde, Xiaowen Wang, Pablo Garcia-Pavia, et al.
The New England Journal of Medicine
|
September 1, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
Pablo Garcia-Pavia, Martin S Maron, Ahmad Masri, et al.
The New England Journal of Medicine
|
May 13, 2024
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Martin S Maron, Ahmad Masri, Michael E Nassif, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 362) with videos related to
Sort By:
Page
of 37
European Journal of Heart Failure
|
August 15, 2019
Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry
Maja Cikes, Nina Jakus, Brian Claggett, et al.
Circulation. Genomic and Precision Medicine
|
January 24, 2025
Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy
Alexandra Butters, Clare Arnott, Joanna Sweeting, et al.
JAMA
|
December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial
Orly Vardeny, KyungMann Kim, Jacob A Udell, et al.
Circulation
|
November 19, 2021
Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial
Marc A Pfeffer, Brian Claggett, Eldrin F Lewis, et al.
BMJ Open
|
May 25, 2022
Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis
Joseph E Ebinger, Sandy Joung, Yunxian Liu, et al.
The New England Journal of Medicine
|
November 10, 2021
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction
Marc A Pfeffer, Brian Claggett, Eldrin F Lewis, et al.
Circulation
|
November 19, 2019
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF
John J V McMurray, Alice M Jackson, Carolyn S P Lam, et al.
Journal of the American College of Cardiology
|
September 11, 2025
Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM
Sheila M Hegde, Xiaowen Wang, Pablo Garcia-Pavia, et al.
The New England Journal of Medicine
|
September 1, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
Pablo Garcia-Pavia, Martin S Maron, Ahmad Masri, et al.
The New England Journal of Medicine
|
May 13, 2024
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Martin S Maron, Ahmad Masri, Michael E Nassif, et al.
Page
of 37